Leerink Partners Initiates Coverage On Opus Genetics with Outperform Rating, Announces Price Target of $10
Opus Genetics Inc IRD
$4.25
▲ +2.66%
(+$0.11)
Open
$4.15
Prev Close
$4.14
Day Range
$4.09 – $4.27
52W Range
$0.90 – $5.81
Market Cap
$336.98M
Beta
0.55
EPS (TTM)
$-1.32
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-11-30 |
| Shares Out. | 81,400,000 |
| Website | opusgtx.com/ ↗ |
| Phone | 12486819815 |
Opus Genetics Inc is a publicly traded company under the ticker symbol IRD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-05-01)